Canadian Cardiovascular Society

Hypertrophic Cardiomyopathy Learning Series

Welcome to the Hypertrophic Cardiomyopathy Learning Series

The Canadian Cardiovascular Society’s Hypertrophic Cardiomyopathy Learning Series is a six-part educational series designed to support learning and to refine the knowledge and skills of specialists and primary care providers on topics related to Hypertrophic Cardiomyopathy.

The multi-pronged and multi-modal program includes three MOC Section 1 accredited webinars, and three MOC Section 3 accredited programs.

Hypertrophic Cardiomyopathy Learning Series 2.0

Program Chairs:

Dr. Michael Chetrit
Dr. Anil Gupta
Dr. Gillian Nesbitt

Past Events:

Session 3: From Guidelines to Breakthroughs – Optimizing Treatment Options for Patients with HCM
Date: October 28, 2023 from 12:30 p.m. to 1:30 p.m. ET 
Location: Vascular 2023 at Palais des congrès de Montréal
Faculty: Dr. Kim Anderson, Dr. Michael Ward, and Dr. Patrick Garceau

Session 2: Unraveling the Puzzle – A Comprehensive Approach to Initial Management of
Symptomatic HCM

Date: September 27, 2023 from 8:00 p.m. to 9:00 p.m. EDT 
Faculty: Dr. Tara Sedlak, Dr. Francois Tournoux, and Dr. Amer Johri 

Session 1: Expressions in HCM: Strategies to Develop a Differential Diagnosis and the Value of Initial Testing
Date: April 26, 2023 from 8:00 p.m. to 9:00 p.m. EDT
Faculty: Dr. Natalie Ho, Dr. Emily Lai, and Dr. Kevin Ong


Hypertrophic Cardiomyopathy Learning Series

Program Chairs:

Dr. Michael Chetrit
Dr. Gillian Nesbitt
Past Events:

Part 1: HCM in Everyday Practice
Date: May 26, 2022 from 8:00 p.m. to 9:00 p.m. EDT
Faculty: Dr. Andrew Frost, Dr. Anil Gupta, Dr. Jacqueline Joza, and Dr. Benedicte Lefebvre


Part 2: Risk Stratification in Hypertrophic CMP
Date: September 7, 2022 from 8:00 p.m. to 9:00 p.m. EDT
Faculty: Dr. Haya Aziz, Dr. Andreas Kumar, Dr. Zachery Laksman, and Dr. Yang Zhan


Part 3: Therapeutics in HCM
Date: October 28, 2022 from 12:30 p.m. to 1:30 p.m. EDT (Accredited Symposia at CCC 2022)
Faculty: Dr. Haya Aziz, Dr. Andreas Kumar, Dr. Zachery Laksman, and Dr. Yang Zhan

This program was made possible through an educational grant from Bristol Myers Squibb and was planned to achieve scientific integrity, objectivity, and balance.

 

Back to top